U.K. grants $192.4 million to researchers

Friday, August 9, 2013 01:20 PM

The National Institute for Health Research (NIHR) has granted $192.4 million to health researchers across the U.K. to tackle the nation’s most pressing health problems.

Health minister Lord Howe said the investment will help patients benefit from innovative new treatments and techniques which could revolutionize future healthcare. It is hoped the financial boost also will help stimulate the research economy and attract more research funding in the future.

“With a growing elderly population, the need for innovative and effective solutions has never been more important,” said Howe.

Researchers from 13 teams across the country will spend the next five years working on their projects, which include work to reduce the risk of dementia through exercise as well as strategies to improve the nutrition and health of those who have already been diagnosed, ways to improve the diagnosis of chronic obstructive pulmonary disease, better aftercare for stroke patients and work to prevent at-risk groups from developing diabetes.

Other projects aim to reduce pressures on A&E and include trying to cut down admissions in children under age five and people with long-term conditions.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs